A detailed history of Allstate Investment Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Allstate Investment Management CO holds 110,529 shares of BMY stock, worth $6.38 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
110,529
Holding current value
$6.38 Million
% of portfolio
0.24%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $7.57 Million - $8.96 Million
110,529 New
110,529 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Allstate Investment Management CO Portfolio

Follow Allstate Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Investment Management CO with notifications on news.